NCT04365673

LACE+ and MRS Score Readmission Rate Assessment

Comparing the Predictive Strength of the LACE+ Index With the MedWise Rise Score on Hospital Readmission Rates: a Non-inferiority Observational Study

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: Tabula Rasa HealthCare · Industry
• Sex: All
• Age: 18 Years – 88 Years
• Healthy volunteers: Not accepted

Summary

A study to demonstrate that the LACE+ score in non-inferior to the medication risk score when predicting 30-day readmission post hospital discharge.

Detailed description

The objective of this study is evaluate a program that provides transition of care services to a local Tucson hospital involving activities designed to reduce 30 day post hospital discharge readmission rates. The organization has had a fee for service contract with this hospital since 2017 to provide pharmacist delivered transition of care services. The organization collects internal tracking outcome data as part of the contract deliverable and is required to report it to the hospital once per month. The investigators look to assess LACE+ and medication risk scores to learn if there is an association with the 30 day post hospital discharge readmission rate post pharmacist intervention. The outcomes will not be generalizable and will be reported back to the hospital client to demonstrate value added.

Conditions

• Hospitalism

Interventions

Type	Name	Description
OTHER	Pharmacist transition of care consultation	Pharmacist-delivered comprehensive medication review

Timeline

• Start date: 2020-07-07
• Primary completion: 2021-03-01
• Completion: 2021-03-01
• First posted: 2020-04-28
• Last updated: 2022-03-17

Locations

1 site across 1 country: United States